Radiotherapy toxicity

D De Ruysscher, G Niedermann, NG Burnet… - Nature Reviews …, 2019 - nature.com
Radiotherapy is used in> 50% of patients with cancer, both for curative and palliative
purposes. Radiotherapy uses ionizing radiation to target and kill tumour tissue, but normal …

Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification

C Bergom, JA Bradley, AK Ng, P Samson, C Robinson… - Cardio Oncology, 2021 - jacc.org
Radiation therapy is an important component of cancer therapy for many malignancies. With
improvements in cardiac-sparing techniques, radiation-induced cardiac dysfunction has …

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools …

AR Lyon, S Dent, S Stanway, H Earl… - European journal of …, 2020 - Wiley Online Library
This position statement from the Heart Failure Association of the European Society of
Cardiology Cardio‐Oncology Study Group in collaboration with the International Cardio …

[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice

MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines

EC de Baat, RL Mulder, S Armenian… - Cochrane Database …, 2022 - cochranelibrary.com
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer
receiving anthracyclines - de Baat, EC - 2022 | Cochrane Library Skip to Content Cookies Our …

Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the …

MJ Ehrhardt, JM Leerink, RL Mulder… - The Lancet …, 2023 - thelancet.com
Survivors of childhood, adolescent, and young adult cancer, previously treated with
anthracycline chemotherapy (including mitoxantrone) or radiotherapy in which the heart was …

Long-term care for people treated for cancer during childhood and adolescence

ES Tonorezos, RJ Cohn, AW Glaser, J Lewin, E Poon… - The Lancet, 2022 - thelancet.com
Worldwide advances in treatment and supportive care for children and adolescents with
cancer have resulted in a increasing population of survivors growing into adulthood. Yet, this …

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline …

SH Armenian, MM Hudson, RL Mulder… - The Lancet …, 2015 - thelancet.com
Survivors of childhood cancer treated with anthracycline chemotherapy or chest radiation
are at an increased risk of developing congestive heart failure. In this population, congestive …

Survivors of childhood and adolescent cancer: life-long risks and responsibilities

LL Robison, MM Hudson - Nature Reviews Cancer, 2014 - nature.com
Survival rates for most paediatric cancers have improved at a remarkable pace over the past
four decades. In developed countries, cure is now the probable outcome for most children …

[HTML][HTML] Guidelines: Editor's choice: 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European …

MF Piepoli, AW Hoes, S Agewall, C Albus… - European heart …, 2016 - ncbi.nlm.nih.gov
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …